Cargando…
MiR-320b and miR-320d as Biomarkers to Predict and Participate in the Formation of Platinum Resistance in Ovarian Cancer Patients
Patients with ovarian cancer who receive platinum-based chemotherapy typically develop platinum resistance, which leads to tumor recurrence and mortality. Therefore, finding the underlying mechanisms and biomarkers is critical. A total of 51 platinum-resistant and 70 platinum-sensitive ovarian cance...
Autores principales: | Liu, Yuan-Yuan, Zhao, Ren-Feng, Liu, Chao, Zhou, Jie, Yang, Liu, Li, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110861/ https://www.ncbi.nlm.nih.gov/pubmed/35592674 http://dx.doi.org/10.3389/fonc.2022.881496 |
Ejemplares similares
-
Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer
por: Wang, Shiwen, et al.
Publicado: (2022) -
The double face of miR-320: cardiomyocytes-derived miR-320 deteriorated while fibroblasts-derived miR-320 protected against heart failure induced by transverse aortic constriction
por: Zhang, Xudong, et al.
Publicado: (2021) -
Circulating miR-1290 and miR-320d as Novel Diagnostic Biomarkers of Human Colorectal Cancer
por: Liu, Xiangxiang, et al.
Publicado: (2019) -
miR-320a is an independent prognostic biomarker for invasive breast cancer
por: YANG, HAIPING, et al.
Publicado: (2014) -
MiR-320e is a novel prognostic biomarker in colorectal cancer
por: Perez-Carbonell, L, et al.
Publicado: (2015)